Statins and diabetes mellitus: risks and benefits
Patients with diabetes mellitus (DM) are at a high risk of cardiovascular events (CVE). Currently, the predominant clinical strategy of the CVE prevention in DM patients is aggressive lowering of low-density lipoprotein cholesterol and blood pressure levels. In this clinical group, statins are among...
Saved in:
| Main Authors: | O. M. Drapkina, O. N. Korneeva, A. F. Sheptulina |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
«SILICEA-POLIGRAF» LLC
2012-12-01
|
| Series: | Кардиоваскулярная терапия и профилактика |
| Subjects: | |
| Online Access: | https://cardiovascular.elpub.ru/jour/article/view/2038 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
STATINS AND THE RISK OF DIABETES MELLITUS
by: O. M. Drapkina
Published: (2015-09-01) -
Statin use and risk of diabetes mellitus
by: Oksana Mikhailovna Drapkina, et al.
Published: (2012-06-01) -
Statins and diabetes mellitus: price of collaboration
by: Andrey Alexeevich Aleksandrov, et al.
Published: (2012-06-01) -
STATINS AND RISK OF INFECTIOUS DISEASES
by: O. M. Drapkina, et al.
Published: (2015-09-01) -
Prescribing frequency and adherence to statins in outpatients with type 2 diabetes mellitus and comorbid cardiovascular diseases
by: Victoriya N. Serebryakova, et al.
Published: (2021-01-01)